Search Results 51-60 of 16792 for random glucose
About this study. Determine the effect of endocrine pancreas morphology, turnover and dedifferentiation on glucose tolerance in humans. Participation ...
The purpose of this study is to to prove that personal real time CGMs brought in the hospital at the time of hospitalization can be safely used to guide insulin ...
About this study. A non-invasive wrist-based photoplethysmography (PPG) sensor may detect changes in blood glucose level and blood pressure.
The purpose of this study is to determine if the set-point for fasting insulin secretion, and the subsequent response to hyperglycemia, is altered in people ...
Also, to see if continous glucose monitor: (CGM) data will facilitate improved antihyperglycemic decision making in diabetic patients. Participation ...
The purpose of this study is to determine if changes in fasting glucose and FFA concentrations alter 1st phase insulin secretion and proinsulin secretion in non ...
The purpose of this study evaluates a subset of people with isolated Impaired Fasting Glucose with Normal Glucose Tolerance (i.e., IFG/NGT) believed to have ...
The purpose of this study is to evaluate the acute effects of a single session of RMT on blood glucose (BG) levels, BP and metabolic responses (e.g., oxygen ...
Fasting glucose ≥ 126 mg/dL;; Two-hour OGTT glucose ≥ 200 mg/dL;; HbA1c ≥ 6.5% documented;; Random glucose ≥ 200 mg/dL with symptoms;; No data at diagnosis ...
Stage 2: two or more positive diabetes autoantibodies and asymptomatic dysglycemia (fasting glucose, 100-125 mg/dL; two-hour glucose, 140-199 mg/dL; or A1C 5.7% ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.